Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma
Authors
Keywords
Adenocarcinoma of the lung, Adenocarcinomas, Lung and intrathoracic tumors, Non-small cell lung cancer, Small interfering RNAs, Flow cytometry, Apoptosis, Secondary lung tumors
Journal
PLoS One
Volume 10, Issue 5, Pages e0127092
Publisher
Public Library of Science (PLoS)
Online
2015-05-16
DOI
10.1371/journal.pone.0127092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies
- (2014) Amir Hossein Daneshmanesh et al. BRITISH JOURNAL OF HAEMATOLOGY
- The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells
- (2014) Alessandra Gentile et al. INTERNATIONAL JOURNAL OF CANCER
- Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
- (2014) Travis W. Bainbridge et al. PLoS One
- The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapy
- (2014) Mohammad Hojjat-Farsangi et al. SEMINARS IN CANCER BIOLOGY
- Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients
- (2014) Stoyan Naidenov Bichev et al. CELLULAR ONCOLOGY
- Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
- (2013) M. Beau-Faller et al. ANNALS OF ONCOLOGY
- Mechanisms of resistance to EGFR targeted therapies
- (2013) Gorjan Hrustanovic et al. CANCER BIOLOGY & THERAPY
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma
- (2013) Jacques Cadranel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Novel therapeutic targets in non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. CURRENT OPINION IN PHARMACOLOGY
- Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- ROR1 can interact with TCL1 and enhance leukemogenesis in E -TCL1 transgenic mice
- (2013) G. F. Widhopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
- (2013) M. J. Niederst et al. Science Signaling
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
- (2012) Tomoya Yamaguchi et al. CANCER CELL
- Lung cancer in never smokers – A review
- (2012) Sébastien Couraud et al. EUROPEAN JOURNAL OF CANCER
- Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
- (2012) A H Daneshmanesh et al. LEUKEMIA
- Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies
- (2012) Amir Hossein Daneshmanesh et al. LEUKEMIA & LYMPHOMA
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
- (2011) A. Gentile et al. CANCER RESEARCH
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia
- (2011) H. Elizabeth Broome et al. LEUKEMIA RESEARCH
- Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
- (2011) Jiahui Yang et al. PLoS One
- The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
- (2010) M. Hudecek et al. BLOOD
- Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
- (2010) Aniruddha Choudhury et al. BRITISH JOURNAL OF HAEMATOLOGY
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
- (2008) Amir H. DaneshManesh et al. INTERNATIONAL JOURNAL OF CANCER
- Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia
- (2008) Mahdi Shabani et al. LEUKEMIA & LYMPHOMA
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started